CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 132 filers reported holding CYTOKINETICS INC in Q4 2017. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $278,000 | -80.0% | 5,748 | -85.2% | 0.04% | -73.9% |
Q3 2021 | $1,392,000 | +82.0% | 38,942 | -46.0% | 0.14% | +59.6% |
Q4 2019 | $765,000 | +309.1% | 72,066 | +458.7% | 0.09% | +584.6% |
Q3 2017 | $187,000 | -88.9% | 12,900 | -90.2% | 0.01% | -85.7% |
Q1 2017 | $1,690,000 | +37.0% | 131,502 | +11.5% | 0.09% | +51.7% |
Q4 2015 | $1,234,000 | +887.2% | 117,931 | +532.5% | 0.06% | +900.0% |
Q3 2015 | $125,000 | -89.0% | 18,644 | -88.8% | 0.01% | -86.7% |
Q1 2015 | $1,133,000 | – | 167,074 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |